U.S. issues initial Medicare drug price negotiation guidance

By Ahmed Aboulenein and Michael Erman WASHINGTON (Reuters) -The U.S. government will select the Medicare program’s 10 costliest prescription medicines based on gross spending for negotiating price cuts that will go into effect in 2026, the U.S. Centers for Medicare and Medicaid Services (CMS) said on Wednesday CMS will only accept one formal written counter offer during the negotiation process, but will allow up to three additional in-person or virtual negotiation meetings, the agency said in initial guidance issued on Wednesday for its Medicare drug price negotiation program. The program was …

Read More